Clinical results of economic analysis of patients diabetic retinopathy with macular edema

In the study clinical and economic evaluation of the effectiveness of treatment in 47 patients with diabetic retinopathy (DR) with macular edema was carried out. The patients were under supervision during 1 year. A total of 92 intravitreal injections of ranibizumab and 112 laser treatments were performed. 3 201 446,00 rubles was spent on the treatment of 47 patients. According to a subjective evaluation by a scale of 100 the patient’s condition was estimated at an average of 47,3±2,45 points; in a year after the treatment 46,1±2,64 points (p> 0,05). Visual acuity before the treatment was 0,40±0,04, after the treatment it was with 0,36±0,04 (p> 0,05). Height macular edema before the treatment was 375±9,2 microns, after 388±10,4 mm (p> 0,05). It was shown that money efficiency observed in nonproliferative DR where it was possible to stabilize visual function and to reduce the phenomenon of macular edema.

diabetes, diabetic retinopathy, macular edema, laser treatment, the quality of life of patients